4000-520-616
欢迎来到免疫在线!(蚂蚁淘生物旗下平台)  请登录 |  免费注册 |  询价篮
主营:主营:临床生物学、分子生物学、实验室设备、耗材、免疫学及免疫血液等
咨询热线电话
4000-520-616
当前位置: 首页 > 产品中心 > cytokine > Biovendor/IFN-λ2 Murine E. coli/RBG20079005/5 µg
商品详细Biovendor/IFN-λ2 Murine E. coli/RBG20079005/5 µg
Biovendor/IFN-λ2 Murine E. coli/RBG20079005/5 µg
Biovendor/IFN-λ2 Murine E. coli/RBG20079005/5 µg
商品编号: RBG20079005
市场价: ¥0.00
美元价: 0.00
产地: 美国(厂家直采)
公司:
产品分类: 细胞因子
公司分类: cytokine
联系Q Q: 3392242852
电话号码: 4000-520-616
电子邮箱: info@ebiomall.com
商品介绍
  • Regulatory status:RUO
  • Type:Recombinant
  • Source:E. coli
  • Other names:IL-28A
  • Species:Murine

Type

Recombinant

Description

IFN λ1, 2, and 3 (also known as IL-29, IL-28A and IL-28B respectively) are distantly related to the IL-10 family and interferons. All three IFN-lambdas use a distinct receptor system composed of an IFN- λR1 subunit (also called CRF2–12) and IL-10R2 subunit (also called CRF2–14). Signaling through this receptor system induces antiviral defenses similar to, but distinct from, that of type I interferons. Recombinant Murine IFN- λ2 is a 19.8 kDa protein containing 175 amino acid residues.

Amino Acid Sequence

MDPVPRATRLPVEAKDCHIAQFKSLSPKELQAFKKAKDAIEKRLLEKDMRCSSHLISRAWDLKQLQVQERPKALQAEVALTLKVWENMTDSALATILGQPLHTLSHIHSQLQTCTQLQATAEPKPPSRRLSRWLHRLQEAQSKETPGCLEDSVTSNLFRLLTRDLKCVASGDQCV

Source

E. coli

Purity

98%

Biological Activity

Determined by its ability to activate STAT following receptor-ligand interaction.

Endotoxin

Endotoxin level is <0.1 ng/μg of protein (<1EU/μg).

Reconstitution

Centrifuge the vial prior to opening. Reconstitute in water to a concentration of 0.1–1.0 mg/ml. Do not vortex. This solution can be stored at 2–8°C for up to 1 week. For extended storage, it is recommended to further dilute in a buffer containing a carrier protein (example 0.1% BSA) and store in working aliquots at –20°C to –80°C.

Storage/Expiration

 –20°C

品牌介绍
miREIA是一种基于免疫测定的新型miRNA定量方法,涉及从患者样品中分离出的miRNA与互补的生物素化DNA寡核苷酸探针杂交。然后通过固定有完美匹配的DNA / miRNA杂交体的微量滴定板固定的单克隆抗体捕获DNA / RNA杂交体。下一步是复制标准ELISA方案。该测定可在常规免疫测定设备上运行,与标准临床工作流程兼容,不需要扩增步骤,并且包括miRNA分析在内的结果可在不到三个小时的时间内获得。